Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Atomo Diagnostics Ltd. (AU:AT1)
ASX:AT1
Holding AU:AT1?
Track your performance easily
AT1 Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.02 - AU$0.06
Previous CloseAU$0.02
Volume98.96K
Average Volume (3M)289.34K
Market Cap
AU$12.14M
Enterprise Value-AU$480.75K
Total Cash (Recent Filing)AU$12.97M
Total Debt (Recent Filing)AU$340.81K
Price to Earnings (P/E)―
Beta-1.55
Next Earnings
Aug 29, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares OutstandingN/A
10 Day Avg. Volume203,615
30 Day Avg. Volume289,340
Standard Deviation0.20
R-Squared0.06
Alpha-0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)2.39
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Atomo Diagnostics Ltd. News
PremiumCompany Announcements
Atomo Diagnostics Plans Share Issuance to Boost Capital
PremiumCompany Announcements
Atomo Diagnostics AGM: Key Resolutions and Outcomes
PremiumCompany Announcements
Atomo Diagnostics Expands Rapid Testing Innovations
PremiumCompany Announcements
Atomo Diagnostics Lands Major HIV Self-Test Order
PremiumCompany Announcements
Atomo Diagnostics Secures Grant for Innovative Syphilis Test
PremiumCompany Announcements
Atomo Diagnostics Ltd. Schedules Annual MeetingPremiumCompany Announcements
Atomo Diagnostics Affirms Strong Governance
PremiumCompany Announcements
Atomo Diagnostics Shares FY24 InsightsAT1 FAQ
What was Atomo Diagnostics Ltd.’s price range in the past 12 months?
Atomo Diagnostics Ltd. lowest share price was AU$0.02 and its highest was AU$0.06 in the past 12 months.
What is Atomo Diagnostics Ltd.’s market cap?
Currently, no data Available
When is Atomo Diagnostics Ltd.’s upcoming earnings report date?
Atomo Diagnostics Ltd.’s upcoming earnings report date is Aug 29, 2024 which is 116 days ago.
How were Atomo Diagnostics Ltd.’s earnings last quarter?
Atomo Diagnostics Ltd. released its earnings results on Feb 25, 2024. The company reported -AU$0.5 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.5.
Is Atomo Diagnostics Ltd. overvalued?
According to Wall Street analysts Atomo Diagnostics Ltd.’s price is currently Overvalued.
Does Atomo Diagnostics Ltd. pay dividends?
Atomo Diagnostics Ltd. does not currently pay dividends.
What is Atomo Diagnostics Ltd.’s EPS estimate?
Atomo Diagnostics Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Atomo Diagnostics Ltd. have?
Atomo Diagnostics Ltd. has 639,202,330 shares outstanding.
What happened to Atomo Diagnostics Ltd.’s price movement after its last earnings report?
Atomo Diagnostics Ltd. reported an EPS of -AU$0.5 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Atomo Diagnostics Ltd.?
Currently, no hedge funds are holding shares in AU:AT1
---
Atomo Diagnostics Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.63%
12-Months-Change
Fundamentals
Return on Equity
-55.06%
Trailing 12-Months
Asset Growth
-30.93%
Trailing 12-Months
Company Description
Atomo Diagnostics Ltd.
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company develops point of care devices for rapid diagnostic testing. Its device is used to test infectious diseases including COVID-19, viral vs bacterial differentiation and female health. Its offers AtomoRapid RDP Platform with the device including Galileo, Pascal, Newton, Losev, Franklin and Elion. The firm operates in a single segment, being medical device research and development.
---
Technical Analysis
AnteoTech Ltd
―
PYC Therapeutics Limited
―
Recce Pharmaceuticals Ltd.
―
Race Oncology Ltd.
―
---